Delivery Order SPE2DB24D1201-SPE2DB25FJCGM

Award Date 4/15/25
Potential Completion Date 4/16/25
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,387.72 firm-fixed-price delivery order is for the supply of 4,566,611,049 units of 200 mg progesterone capsules. The contract has an ultimate completion date of December 5, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This federal contract award, valued at $4,305.44, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Progesterone 200 mg capsules, with an ultimate completion date of April 21, 2025. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,359.89 firm fixed-price delivery order is for the supply of 4,568,236,190 units of a 200 mg progesterone capsule product. The contract has an ultimate completion date of May 14, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order with a Firm Fixed Price, is for the supply of 4,568,062,572 units of a 200 mg Progesterone capsule in 100-count packages. The contract has a ceiling value of $1,244.25 and a period of performance through April 29, 2025. This award is not a set-aside contract, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,568,202,852 units of Progesterone 200 mg capsules in 100-count packages. The contract has a ceiling value of $24,061.11 and is a firm fixed-price delivery order with a performance period ending on May 12, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,019.74 Delivery Order contract is for the supply of 4,567,600 units of Progesterone 200 mg capsules. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $13,342.99, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567765728 - Progesterone 200 mg Capsules in 100 count bottles. The contract has an ultimate completion date of April 2, 2025 and is a Firm Fixed Price Delivery Order with no set-aside designation. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award, valued at $12,351.28, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567774636 - Progesterone 200 mg Capsule 30s, with an ultimate completion date of April 3, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of 100 milligram progesterone capsules. The contract is a firm fixed-price delivery order with a ceiling value of $1,617.62 and a performance period through June 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,456.09, is a delivery order for the supply of 4567726860 - Progesterone 100 mg Capsule 100s. The contract has an ultimate completion date of March 31, 2025 and uses a firm fixed price pricing type. This contract award is associated with AmerisourceBergen's larger Indefinite Delivery Contract...
  • SPE2DB24D1201
    Indefinite Delivery Contract
  • SPE2DB24D1201-SPE2DB25FJCGM
    Delivery Order

This federal contract award, valued at $11,961.65, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,567,925,357 units of Progesterone 200 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 16, 2025.

Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract award is not designated as a set-aside, indicating open competition. As a major pharmaceutical distributor and healthcare solutions provider, Amerisourcebergen Drug Corp is a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/15/25, 3:31 PM